The Union Ministry of Health and Family Welfare has proposed amendments to the Drugs Rules, 1945, to enable immediate suspension of manufacturing licences for medicines that fail specified critical quality parameters.
The proposed changes aim to strengthen pharmaceutical quality control and improve patient safety by allowing faster regulatory intervention against substandard medicines.
Under the proposed mechanism, manufacturing licences could be suspended following a government analyst’s report identifying a failure in critical quality requirements. Manufacturers would be required to conduct a root cause analysis and implement corrective and preventive actions before their licences could be restored.
The proposed amendments cover parameters such as impurities, sterility, active ingredient content and dissolution. These factors play an important role in determining the safety, effectiveness and quality of medicines.
The ministry has also proposed a system for sharing laboratory findings with the Central Drugs Standard Control Organisation, state and Union Territory licensing authorities, manufacturers and marketers of the concerned medicines.
The existing regulatory process generally involves issuing notices and allowing manufacturers to respond before suspension or cancellation of licences. The proposed framework seeks to reduce delays in regulatory intervention.
The move comes amid continued scrutiny of pharmaceutical quality standards in India. Substandard medicines can pose serious risks to patients, particularly when used to treat infections and other serious medical conditions.
The ministry’s proposal is intended to prevent the continued manufacture and distribution of medicines that fail critical quality standards.
The draft amendments are expected to undergo the prescribed consultation process before final notification.
The proposal represents a potential strengthening of India’s pharmaceutical regulatory framework, with a focus on ensuring that medicines available to patients meet established quality requirements.
The proposed amendments are not yet final rules.
Comment here